These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38987413)

  • 1. Descriptive Trends in Medicaid Antipsychotic Prescription Claims and Expenditures, 2016 - 2021.
    Giron NC; Oh H; Rehmet E; Shireman TI
    J Behav Health Serv Res; 2024 Oct; 51(4):516-528. PubMed ID: 38987413
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic use and expenditure in the United States.
    Aparasu RR; Bhatara V
    Psychiatr Serv; 2006 Dec; 57(12):1693. PubMed ID: 17158480
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in retail prescription expenditures.
    Schondelmeyer SW; Thomas J
    Health Aff (Millwood); 1990; 9(3):131-45. PubMed ID: 2121634
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors Associated with Geographic Variation in Psychiatric Prescription Drug Expenditures Among Medicaid Beneficiaries.
    Zur J; Ku L
    J Behav Health Serv Res; 2016 Jul; 43(3):504-12. PubMed ID: 26206490
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric prescribing trends and practices in Iowa's prisons.
    Lund BC; Flaum M; Adam LA; Perry PJ
    Psychiatr Serv; 2002 Aug; 53(8):1023-4. PubMed ID: 12161679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number Of Medicaid Prescriptions Grew, Drug Spending Was Steady In Medicaid Expansion States.
    Wen H; Borders TF; Druss BG
    Health Aff (Millwood); 2016 Sep; 35(9):1604-7. PubMed ID: 27605639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Need for therapeutic guidelines for antipsychotics under a prescription cap.
    Sutherland LG
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S19-22. PubMed ID: 9872690
    [No Abstract]   [Full Text] [Related]  

  • 9. Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth.
    Spence O; Reeves G; dosReis S
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1064-1071. PubMed ID: 32558177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecasting Medicaid Expenditures for Antipsychotic Medications.
    Slade EP; Simoni-Wastila L
    Psychiatr Serv; 2015 Jul; 66(7):713-8. PubMed ID: 25828875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced drug coverage saved Medicaid 'pennies,' cost state 'pounds'.
    Am J Hosp Pharm; 1994 Nov; 51(21):2622. PubMed ID: 7856574
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug use and expenditures among dually eligible beneficiaries.
    Bagchi AD; Esposito D; Verdier JM
    Health Care Financ Rev; 2007; 28(4):43-56. PubMed ID: 17722750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Drug Use and Cost Trends Among Medicaid-Enrolled Children with Disruptive Behavioral Disorders.
    Zhao L; Cross-Barnet C; McClair VL
    J Behav Health Serv Res; 2018 Oct; 45(4):550-564. PubMed ID: 29572707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
    Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
    J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to trends in prescription drug expenditures.
    Suh DC; Lacy CR; Barone JA; Moylan D; Kostis JB
    Clin Ther; 1999 Jul; 21(7):1241-53. PubMed ID: 10463521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.